COMPARATIVE ANALYSIS BETWEEN BROAD-SPECTRUM AND NARROW-SPECTRUM ANTIBIOTICS USED
DOI:
https://doi.org/10.22159/ijpps.2025v17i4.53548Keywords:
Comparative analysis, Anti-microbial resistance, Treatment regimen, PrevalenceAbstract
Objective: The main objective of this study was to compare the effectiveness of empiric treatment with broad-spectrum therapy versus narrow-spectrum therapy for a patient hospitalized in the intensive care unit of a tertiary care hospital in Latur, Maharashtra, India.
Methods: An institutional-based retrospective observational study was conducted at a tertiary care hospital in an intensive care unit from December 2023 to May 2024. The data was collected using a patient profile form and analyzed using the data analysis tool Microsoft Excel. Mann-Whitney U test was used to associate dichotomous variables. A P-value of (0.03) was of significant statistics.
Results: A total of 150 patients were included in the study between December 2023 to May 2024. The majority of them were male 92(61%) and 58 (39%) were female. The majority of the study participants received broad-spectrum antibiotics. Broad-spectrum antibiotics prescribed were (53%) and the remaining (47%) were narrow spectrum. We highlighted the need for an antibiogram in the intensive care unit and also urged the policymakers to introduce antimicrobial stewardship programs and guidelines in healthcare institutes that will help with planning future initiatives among the tertiary care hospitals of India.
Conclusion: There was a difference in the prescribing pattern of antibiotics on their spectrum of activity. Most broad-spectrum antibiotics were prescribed in the hospital to assess early health benefits. Treatment regimens for patients should be selected based on their safety profile and their tendency for antibiotic resistance.
Downloads
References
Borah M, Khanikar D, Chakraborty SS, Charkraborty A, Devi D, Dudhraj V, Bahl A. Point prevalence survey of antimicrobial consumption in a Tertiary Care Hospital of North East India. Int J Pharm Pharm Sci. 2024 Dec 1;16(12):31–6. doi: 10.22159/ijpps.2024v16i12.52442
Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742-50. doi: 10.1016/S1473-3099(14)70780-7, PMID 25022435.
Bhat P, Bhumbla U, Kaur J. War in the middle ear: microbiology of chronic suppurative otitis media with special reference to anaerobes and its antimicrobial susceptibility pattern: optimizing antimicrobial therapy in a Tertiary Care Hospital of Rural India. Int J Pharm Pharm Sci. 2025 Jan 1;17(1):12-20. doi: 10.22159/ijpps.2025v17i1.52692.
Williams A, Mathai AS, Phillips AS. Antibiotic prescription patterns at admission into a tertiary level intensive care unit in Northern India. J Pharm Bioallied Sci. 2011 Oct;3(4):531-6. doi: 10.4103/0975-7406.90108, PMID 22219587.
Hashmi H, Sasoli NA, Sadiq A, Raziq A, Batool F, Raza S. Prescribing patterns for upper respiratory tract infections: a prescription-review of primary care practice in Quetta, Pakistan and the implications. Front Public Health. 2021 Nov 19;9:787933. doi: 10.3389/fpubh.2021.787933, PMID 34869195.
Kotwani A, Holloway K. Trends in antibiotic use among outpatients in New Delhi, India. BMC Infect Dis. 2011 Apr 20;11:99. doi: 10.1186/1471-2334-11-99, PMID 21507212.
Prost M, Rockner ME, Vasconcelos MK, Windolf J, Konieczny MR. Outcome of targeted vs empiric antibiotic therapy in the treatment of spondylodiscitis: a retrospective analysis of 201 patients. Int J Spine Surg. 2023;17(4):607-14. doi: 10.14444/8482, PMID 37460238.
Ghosh S, Salhotra R, Singh A, Lyall A, Arora G, Kumar N. New antibiotic prescription pattern in critically ill patients (‘ant-critic’): prospective observational study from an Indian Intensive Care Unit. Indian J Crit Care Med. 2022 Dec 1;26(12):1275-84. doi: 10.5005/jp-journals-10071-24366, PMID 36755637.
Driessen RG, Groven RV, Van Koll J, Oudhuis GJ, Posthouwer D, Van der Horst IC. Appropriateness of empirical antibiotic therapy and added value of adjunctive gentamicin in patients with septic shock: a prospective cohort study in the ICU. Infect Dis (Lond). 2021;53(11):830-8. doi: 10.1080/23744235.2021.1942543, PMID 34156899.
BG D, D CA, NN M, HN P. Study of prescribing pattern of antimicrobial agents in medicine intensive care unit of a Tertiary Care Hospital. Asian J Pharm Clin Res. 2020 Mar 20:136-40.
Mettler J, Simcock M, Sendi P, Widmer AF, Bingisser R, Battegay M. Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: a prospective observational study. BMC Infect Dis. 2007 Mar 26;7:21. doi: 10.1186/1471-2334-7-21, PMID 17386104.
Alharthi N, Kenawy G, Eldalo A. Antibiotics’ prescribing pattern in intensive care unit in Taif, Saudi Arabia. Saudi J Health Sci. 2019;8(1):47. doi: 10.4103/sjhs.sjhs_12_19.
Ghafur A. The chennai declaration: a solution to the antimicrobial resistance problem in the Indian subcontinent. Clin Infect Dis. 2013;56(8):1190. doi: 10.1093/cid/cis1224, PMID 23307765.
Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. 2019;51:72-80. doi: 10.1016/j.mib.2019.10.008, PMID 31733401.
Zhu Y, Huang WE, Yang Q. Clinical perspective of antimicrobial resistance in bacteria. Infect Drug Resist. 2022;15:735-46. doi: 10.2147/IDR.S345574, PMID 35264857.
Ganguly NK. Professor of biotechnology D, Nair Kapoor A, Joshi PC, Joglekar S, Arora NK. India: Global Antibiotic Resistance Partnership (GARP. India) National Working Group (NWG) GARP-India staff; 2008.
WHO library cataloging-in-publication data global action plan on antimicrobial resistance; 2015.
Van Boeckel TP, Brower C, Gilbert M, Grenfell BT, Levin SA, Robinson TP. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA. 2015 May 5;112(18):5649-54. doi: 10.1073/pnas.1503141112, PMID 25792457.
Jain S, Das Chugh T. Antimicrobial resistance among blood culture isolates of Salmonella enterica in New Delhi. J Infect Dev Ctries. 2013;7(11):788-95. doi: 10.3855/jidc.3030, PMID 24240035.
Antibiotic Resistance: multi-country public awareness survey; 2015.
Adhikari L. High-level aminoglycoside resistance and reduced susceptibility to vancomycin in nosocomial enterococci. J Glob Infect Dis. 2010;2(3):231-5. doi: 10.4103/0974-777X.68534, PMID 20927283.
Mehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect. 2007 Oct;67(2):168-74. doi: 10.1016/j.jhin.2007.07.008, PMID 17905477.
D’Souza N, Rodrigues C, Mehta A. Molecular characterization of methicillin-resistant staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India. J Clin Microbiol. 2010 May;48(5):1806-11. doi: 10.1128/JCM.01867-09, PMID 20351212.
Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42-51. doi: 10.1038/nrmicro3380, PMID 25435309.
Dutta S, Haque M. COVID-19: questions of antimicrobial resistance. Bangladesh J Med Sci. 2021;20(2):221-7. doi: 10.3329/bjms.v20i2.51527.
Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309-18. doi: 10.1179/2047773215Y.0000000030, PMID 26343252.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Neha Kotekar, Vishal Pawar, Dr. Ashok Giri
This work is licensed under a Creative Commons Attribution 4.0 International License.
